Scaffold Protein p140Cap as a Molecular Hub for Limiting Cancer Progression : : A New Paradigm in Neuroblastoma / / written by Giorgia Centonze [and eight others].
Neuroblastoma, the most common extra-cranial pediatric solid tumor, is responsible for 9-15% of all pediatric cancer deaths. Its intrinsic heterogeneity makes it difficult to successfully treat, resulting in overall survival of 50% for half of the patients. Here we analyze the role in neuroblastoma...
Saved in:
VerfasserIn: | |
---|---|
Place / Publishing House: | London : : IntechOpen,, 2021. |
Year of Publication: | 2021 |
Language: | English |
Physical Description: | 1 online resource (130 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- 1. Introduction
- 2. The p140Cap adaptor protein
- 3. SRCIN1 mRNA expression is an independent prognostic marker for NB
- 4. p140Cap negatively affects tumorigenic features
- 5. Molecular mechanisms and therapeutic targets in neuroblastoma
- 6. p140Cap impairs the Src/p130Cas and the STAT3/Jak2 signaling pathways
- 7. p140Cap increases NB cell sensitivity to chemotherapeutic treatment
- 8. p140Cap increases NB cell sensitivity to Src kinase inhibitors
- 9. Conclusions
- Acknowledgments
- Conflict of interest
- Rights and permissions
- Abbreviations
- References.